T0	Participants 73 131	overweight and obese subjects with cardiovascular disease.
T1	Participants 313 408	overweight and obese subjects receiving long-term sibutramine treatment with diet and exercise.
T2	Participants 620 768	A total of 9804 male and female subjects, aged 55 years or older, with a body mass index of 27-45 kg m(-2) were included in this current subanalysis
T3	Participants 798 1002	were required to have a history of cardiovascular disease and/or type 2 diabetes mellitus with at least one cardiovascular risk factor (hypertension, dyslipidemia, current smoking or diabetic nephropathy)
T4	Participants 2202 2252	to be harmful in this obese elderly cardiovascular